Professor Gall received his BS, MS, and PhD from the University of Illinois Champaign-Urbana in Mechanical Engineering. He is currently the Chair of Mechanical Engineering and Materials Science at Duke University. His technical expertise is in the creation, modification, understanding, and commercialization of synthetic biomaterials. On the academic side, his materials publications have been cited approximately 16,000 times with an H-index of 69. On the commercial side, he has founded multiple medical device start-ups, including MedShape, Vertera, and Restor3d. MedShape is a fully functioning medical device company developing implants for foot and ankle reconstruction based on shape memory materials. MedShape’s sports medicine division was acquired by Conmed (NASDAQ:CNMD). Vertera created the first spinal fusion implants based on porous polymer technologies and was acquired by Nuvasive (NASDAQ:NUVA). Restor3d is a new venture utilizing 3D printing of polymers and metals to create unique patient-specific implants on demand across multiple fields of medicine.